• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cardica plunges after pulling MicroCutter Xchange 30 stapler

Cardica plunges after pulling MicroCutter Xchange 30 stapler

November 19, 2014 By Val Kennedy

Cardica plunges after pulling MicroCutter Xchange 30 stapler

Cardica (NSDQ:CRDC) said it suspended the launch of its MicroCutter Xchange 30 surgical stapler so it can focus on improving the product, a move that may also result in a realignment of its operations. The news sent CRDC shares down more than 22% yesterday.

The Redwood City, Calif.-based company said about 220 units of the product were distributed as part of a “controlled commercial launch” to solicit feedback on its performance. Cardica said expects surgeons to continue using the approximately 100 units that remain in the field. The company plans to conduct a full commercial launch of the product once certain improvements are made.

Cardica will also reexamine its business “to focus on conserving cash by aligning spending with its focused plan going forward,” the company said.

"After further analysis of Cardica’s operations, including timing and budget, Cardica will provide an update to stockholders," according to a statement.

Shares of the micro-cap stock closed down 22.4% at 66¢ apiece yesterday and were down another 2.3% today to 64.3¢ as of about 10:15 a.m. Eastern.

Meanwhile, 1 of Cardica’s major stakeholders, Broadfin Capital, launched a proxy battle to replace 3 of the company’s long-time directors with its own nominees. In a letter sent to shareholders last week, Broadfin accused the board of poor corporate governance.

“Since Cardica’s IPO in 2006, the company’s stock price has plummeted by an astounding 91%, the company has missed analyst expectations 78% of the time and milestones in 59% of the cases, and universally compares terribly to all relative indices over any measurable period of time. In addition, as a result of continued operational missteps and the ineffective oversight of a board that lacks both independence and surgical markets expertise, Cardica is poorly positioned to capitalize on its unique and valuable ‘staple-on-strip’ technology,” Broadfin alleged.

Cardica’s annual meeting is scheduled for Dec. 11, according to Broadfin.

Filed Under: News Well, Surgical, Wall Street Beat Tagged With: Broadfin Capital, dextera

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy